The DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics
Open accessAbstract
The metalloproteinase (MP) family of zinc-dependent proteases, including matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs), and a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTSs) plays a crucial role in the extracellular matrix (ECM) remodeling and degradation activities. A wide range of substrates of the MP family includes ECM components, chemokines, cell receptors, and growth factors. Metalloproteinases activities are tightly regulated by proteolytic activation and inhibition via their natural inhibitors, tissue inhibitors of metalloproteinases (TIMPs), and the imbalance of the activation and inhibition is responsible in progression or inhibition of several diseases, e.g., cancer, neurological disorders, and cardiovascular diseases. We provide an overview of the structure, function, and the multifaceted role of MMPs, ADAMs, and TIMPs in several diseases via their cellular functions such as proteolysis of other cell signaling factors, degradation and remodeling of the ECM, and other essential protease-independent interactions in the ECM. The significance of MP inhibitors targeting specific MMP or ADAMs with high selectivity is also discussed. Recent advances and techniques used in developing novel MP inhibitors and MP responsive drug delivery tools are also reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Han, M., Gao, H. Y., Ju, P., Gao, M., Yuan, Y., Chen, X., Liu, K.-L., Han, Y., & Han, Z. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.014 · Cited by 95
RetractedGhasemi, A., Hashemy, S. I., Aghaei, M., & Panjehpour, M. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26396 · Cited by 53
RetractedGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151 · cited 4×
“Other binding interactions include heparan sulfate proteoglycans, collagen type IV, or extracellular matrix metalloproteinase inducer (EMMPRIN) [18].”
BackgroundInfluentialCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
Galis, Z. S., & Khatri, J. J. (2002) · PubMed · Cited by 1,787
Yeast surface display for screening combinatorial polypeptide libraries
Boder, E. T., & Wittrup, K. D. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-553 · Cited by 1,760
Mechanism Of Cell Surface Activation Of 72-kDa Type IV Collagenase
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., & Goldberg, G. I. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.10.5331 · Cited by 1,593
Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: The Good, the Bad, and the Ugly
Galis, Z. S., & Khatri, J. J. (2002) · Circulation Research · doi:10.1161/res.90.3.251 · Cited by 1,548
Brew, K., & Nagase, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.01.003 · Cited by 1,381
Biochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359 · cited 2×
“MMP structure also includes a hinge region and a hemopexin (PEX) domain [4,16].”
BackgroundMMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
Baker, A. H., Edwards, D. R., & Murphy, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.00063 · Cited by 1,179
An overview of the c-MET signaling pathway
Organ, S. L., & Tsao, M.-S. (2011) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834011422556 · Cited by 875
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Vandenbroucke, R. E., & Libert, C. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4390 · Cited by 832
Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721
Qi, J. H., Ebrahem, Q., Moore, N., Murphy, G., Claesson-Welsh, L., Bond, M., Baker, A., & Anand-Apte, B. (2003) · Nature Medicine · doi:10.1038/nm846 · Cited by 658
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-R¨th, F.-X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G. P., et al. (1997) · Nature · doi:10.1038/37995 · Cited by 619
Ardi, V. C., Kupriyanova, T. A., Deryugina, E. I., & Quigley, J. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706438104 · Cited by 602
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
Cell‐Responsive Synthetic Hydrogels
Lutolf, M. P., Raeber, G. P., Zisch, A. H., Tirelli, N., & Hubbell, J. A. (2003) · Advanced Materials · doi:10.1002/adma.200304621 · Cited by 526
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., & Marmer, B. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42873-6 · Cited by 515
Amyloid fibrils: Abnormal protein assembly
Rambaran, R. N., & Serpell, L. C. (2008) · Prion · doi:10.4161/pri.2.3.7488 · Cited by 511
TIMP-3 Is a Potent Inhibitor of Aggrecanase 1 (ADAM-TS4) and Aggrecanase 2 (ADAM-TS5)
Kashiwagi, M., Tortorella, M., Nagase, H., & Brew, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000848200 · Cited by 509
Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary Fibrosis
Craig, V. J., Zhang, L., Hagood, J. S., & Owen, C. A. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0020tr · Cited by 507
Targeting matrix metalloproteinases in cancer: Bringing new life to old ideas
Cathcart, J., Pulkoski-Gross, A., & Cao, J. (2015) · Genes & Diseases · doi:10.1016/j.gendis.2014.12.002 · Cited by 504
Antibody–drug conjugates as novel anti-cancer chemotherapeutics
Peters, C., & Brown, S. (2015) · Bioscience Reports · doi:10.1042/bsr20150089 · Cited by 492
Stetler-Stevenson, W. G. (2008) · Science Signaling · doi:10.1126/scisignal.127re6 · Cited by 489
Matrix metalloproteinases in liver injury, repair and fibrosis
Duarte, S., Baber, J., Fujii, T., & Coito, A. J. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.004 · Cited by 476
Tissue inhibitors of metalloproteinases
Murphy, G. (2011) · Genome Biology · doi:10.1186/gb-2011-12-11-233 · Cited by 472
TIMPs: versatile extracellular regulators in cancer
Jackson, H. W., Defamie, V., Waterhouse, P., & Khokha, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.115 · Cited by 454
Molecular Link Mechanisms between Inflammation and Cancer
B. Vendramini-Costa, D., & E. Carvalho, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802083707 · Cited by 417
The in vitro activity of ADAM‐10 is inhibited by TIMP‐1 and TIMP‐3
Amour, A., Knight, C. G., Webster, A., Slocombe, P. M., Stephens, P. E., Knäuper, V., Docherty, A. J. P., & Murphy, G. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01528-3 · Cited by 404
Novel functions of TIMPs in cell signaling
Chirco, R., Liu, X.-W., Jung, K.-K., & Kim, H.-R. C. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7893-x · Cited by 401 · cited 1×
“Considering MMP‐independent activities of TIMPs [37,253,254], it is important to define the sequence and”
BackgroundShogan, B. D., Belogortseva, N., Luong, P. M., Zaborin, A., Lax, S., Bethel, C., Ward, M., Muldoon, J. P., Singer, M., An, G., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.3010658 · Cited by 399
Mehner, C., Hockla, A., Miller, E., Ran, S., Radisky, D. C., & Radisky, E. S. (2014) · Oncotarget · doi:10.18632/oncotarget.1932 · Cited by 368
Scheau, C., Badarau, I. A., Costache, R., Caruntu, C., Mihai, G. L., Didilescu, A. C., Constantin, C., & Neagu, M. (2019) · Analytical Cellular Pathology · doi:10.1155/2019/9423907 · Cited by 367
Hadler-Olsen, E., Winberg, J.-O., & Uhlin-Hansen, L. (2013) · Tumor Biology · doi:10.1007/s13277-013-0842-8 · Cited by 366
Selective Inhibition of Matrix Metalloproteinase-14 Blocks Tumor Growth, Invasion, and Angiogenesis
Devy, L., Huang, L., Naa, L., Yanamandra, N., Pieters, H., Frans, N., Chang, E., Tao, Q., Vanhove, M., Lejeune, A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3255 · Cited by 355
Loy, C. T., Schofield, P. R., Turner, A. M., & Kwok, J. B. (2014) · The Lancet · doi:10.1016/s0140-6736(13)60630-3 · Cited by 342
Towards third generation matrix metalloproteinase inhibitors for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603043 · Cited by 340
Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M., & Docherty, A. J. P. (1991) · Biochemistry · doi:10.1021/bi00247a001 · Cited by 324
ADAM 12-S Cleaves IGFBP-3 and IGFBP-5 and Is Inhibited by TIMP-3
Loechel, F., Fox, J. W., Murphy, G., Albrechtsen, R., & Wewer, U. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3835 · Cited by 314
Jacobsen, J. A., Major Jourden, J. L., Miller, M. T., & Cohen, S. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.08.006 · Cited by 313
Selective Use of ADAM10 and ADAM17 in Activation of Notch1 Signaling
Bozkulak, E. C., & Weinmaster, G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00406-09 · Cited by 309
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Fields, G. B. (2019) · Cells · doi:10.3390/cells8090984 · Cited by 299
Pasterkamp, G., Schoneveld, A. H., Hijnen, D. J., de Kleijn, D. P. V., Teepen, H., van der Wal, A. C., & Borst, C. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00371-8 · Cited by 298
Inhibition of ADAM-TS4 and ADAM-TS5 Prevents Aggrecan Degradation in Osteoarthritic Cartilage
Malfait, A.-M., Liu, R.-Q., Ijiri, K., Komiya, S., & Tortorella, M. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200431200 · Cited by 294
Kopan, R. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a011213 · Cited by 294
Matrix Metalloproteinases in Myocardial Infarction and Heart Failure
DeLeon-Pennell, K. Y., Meschiari, C. A., Jung, M., & Lindsey, M. L. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.001 · Cited by 287
MMP-Responsive ‘Smart’ Drug Delivery and Tumor Targeting
Yao, Q., Kou, L., Tu, Y., & Zhu, L. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.06.003 · Cited by 280
MMPs in the central nervous system: Where the good guys go bad
AGRAWAL, S., LAU, L., & YONG, V (2008) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2007.06.003 · Cited by 225
Morgunova, E., Tuuttila, A., Bergmann, U., & Tryggvason, K. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102185399 · Cited by 219
Eckhard, U., Huesgen, P. F., Schilling, O., Bellac, C. L., Butler, G. S., Cox, J. H., Dufour, A., Goebeler, V., Kappelhoff, R., Keller, U. A. D., et al. (2016) · Matrix Biology · doi:10.1016/j.matbio.2015.09.003 · Cited by 212
Matrix Metalloproteinases and Cancer - Roles in Threat and Therapy
Yadav, L., Puri, N., Rastogi, V., Satpute, P., Ahmad, R., & Kaur, G. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1085 · Cited by 209
Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205
Le Pabic, H., Bonnier, D., Wewer, U. M., Coutand, A., Musso, O., Baffet, G., Clément, B., & Théret, N. (2003) · Hepatology · doi:10.1053/jhep.2003.50205 · Cited by 204
Marshall, D. C., Lyman, S. K., McCauley, S., Kovalenko, M., Spangler, R., Liu, C., Lee, M., O’Sullivan, C., Barry-Hamilton, V., Ghermazien, H., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127063 · Cited by 201
Ogata, Y., Itoh, Y., & Nagase, H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18506 · Cited by 201
Multifaceted role of matrix metalloproteinases (MMPs)
Singh, D., Srivastava, S. K., Chaudhuri, T. K., & Upadhyay, G. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00019 · Cited by 192
Remyelination In Multiple Sclerosis
Chari, D. M. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)79026-8 · Cited by 191
Cui, H., Seubert, B., Stahl, E., Dietz, H., Reuning, U., Moreno-Leon, L., Ilie, M., Hofman, P., Nagase, H., Mari, B., et al. (2015) · Oncogene · doi:10.1038/onc.2014.300 · Cited by 190
Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.
Zarrabi, K., Dufour, A., Li, J., Kuscu, C., Pulkoski-Gross, A., Zhi, J., Hu, Y., Sampson, N. S., Zucker, S., & Cao, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256644 · Cited by 188
Selective Vulnerability of Dopaminergic Neurons to Microtubule Depolymerization
Ren, Y., Liu, W., Jiang, H., Jiang, Q., & Feng, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503483200 · Cited by 188
Clinical role of MMP‐2/TIMP‐2 imbalance in hepatocellular carcinoma
Giannelli, G., Bergamini, C., Marinosci, F., Fransvea, E., Quaranta, M., Lupo, L., Schiraldi, O., & Antonaci, S. (2002) · International Journal of Cancer · doi:10.1002/ijc.1635 · Cited by 187
Miller, J. P., Holcomb, J., Al-Ramahi, I., de Haro, M., Gafni, J., Zhang, N., Kim, E., Sanhueza, M., Torcassi, C., Kwak, S., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.021 · Cited by 186
Inhibition of MMPs and ADAM/ADAMTS
Malemud, C. J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.02.033 · Cited by 184
New intracellular activities of matrix metalloproteinases shine in the moonlight
Jobin, P. G., Butler, G. S., & Overall, C. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.013 · Cited by 182
Corbel, M., Belleguic, C., Boichot, E., & Lagente, V. (2002) · Cell Biology and Toxicology · doi:10.1023/a:1014471213371 · Cited by 178
Hypoxia and tissue destruction in pulmonary TB
Belton, M., Brilha, S., Manavaki, R., Mauri, F., Nijran, K., Hong, Y. T., Patel, N. H., Dembek, M., Tezera, L., Green, J., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207402 · Cited by 176
The past, present and future perspectives of matrix metalloproteinase inhibitors
Li, K., Tay, F. R., & Yiu, C. K. Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107465 · Cited by 170
Chase, A. J., Bond, M., Crook, M. F., & Newby, A. C. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000015078.09208.92 · Cited by 167
TIMP-1 Promotes Accumulation of Cancer Associated Fibroblasts and Cancer Progression
Gong, Y., Scott, E., Lu, R., Xu, Y., Oh, W. K., & Yu, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077366 · Cited by 166
Metalloproteinases in idiopathic pulmonary fibrosis
Dancer, R. C. A., Wood, A. M., & THICKETT, D. R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00024711 · Cited by 164
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis
Kieseier, B. (1998) · Brain · doi:10.1093/brain/121.1.159 · Cited by 163
Matrix metalloproteinases as drivers and therapeutic targets in breast cancer
Radisky, E. S. (2015) · Frontiers in Bioscience · doi:10.2741/4364 · Cited by 162
Ardi, V. C., den Steen, P. E. V., Opdenakker, G., Schweighofer, B., Deryugina, E. I., & Quigley, J. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.033472 · Cited by 161
Sela-Passwell, N., Rosenblum, G., Shoham, T., & Sagi, I. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.010 · Cited by 160
The Role of ADAM10 in Alzheimer’s Disease
Yuan, X.-Z., Sun, S., Tan, C.-C., Yu, J.-T., & Tan, L. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170061 · Cited by 160
Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
Radisky, E. S., Raeeszadeh‐Sarmazdeh, M., & Radisky, D. C. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26185 · Cited by 160
Self-citationScannevin, R. H., Alexander, R., Haarlander, T. M., Burke, S. L., Singer, M., Huo, C., Zhang, Y.-M., Maguire, D., Spurlino, J., Deckman, I., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.806075 · Cited by 160
O'Connell, J. P., Willenbrock, F., Docherty, A. J., Eaton, D., & Murphy, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36561-4 · Cited by 158
Engineering antibodies by yeast display
Boder, E. T., Raeeszadeh‐Sarmazdeh, M., & Price, J. V. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.009 · Cited by 158
Self-citationSela-Passwell, N., Kikkeri, R. V., Dym, O., Rozenberg, H., Margalit, R., Arad‐Yellin, R., Eisenstein, M., Brenner, O. J., Shoham, T., Danon, T., et al. (2011) · Nature Medicine · doi:10.1038/nm.2582 · Cited by 158
Cisplatin delivery from poly(acrylic acid-co-methyl methacrylate) microparticles
Yan, X., & Gemeinhart, R. A. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.005 · Cited by 158
Remacle, A. G., Golubkov, V. S., Shiryaev, S. A., Dahl, R. S., Stebbins, J. L., Chernov, A. V., Cheltsov, A. V., Pellecchia, M., & Strongin, A. Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4149 · Cited by 157
Amyloid-β and Parkinson’s disease
Kings Parcog groupMDS Nonmotor study group, Lim, E. W., Aarsland, D., Ffytche, D. H., Taddei, R. N., van Wamelen, D. J., Wan, Y.-M., Tan, E. K., & Chaudhuri, К. R. (2018) · Journal of Neurology · doi:10.1007/s00415-018-9100-8 · Cited by 157
IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis
Huang, M., Sharma, S. P., Zhu, L. X., Keane, M. P., Luo, J., Zhang, L., Burdick, M. D., Lin, Y. Q., Dohadwala, M., Gardner, B. K., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14685 · Cited by 152
Mechanisms of Action of Novel Drugs Targeting Angiogenesis-Promoting Matrix Metalloproteinases
Fields, G. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01278 · Cited by 140
Injectable MMP-Responsive Nanotube-Modified Gelatin Hydrogel for Dental Infection Ablation
Ribeiro, J. S., Bordini, E. A. F., Ferreira, J. A., Mei, L., Dubey, N., Fenno, J. C., Piva, E., Lund, R. G., Schwendeman, A. A., & Bottino, M. C. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b22964 · Cited by 140
Matrix metalloproteinase: An upcoming therapeutic approach for idiopathic pulmonary fibrosis
Mahalanobish, S., Saha, S., Dutta, S., & Sil, P. C. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104591 · Cited by 139
Dufour, A., Sampson, N. S., Li, J., Kuscu, C., Rizzo, R. C., DeLeon, J. L., Zhi, J., Jaber, N. L., Liu, E. V., Zucker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4552 · Cited by 131
Liu, G., Atteridge, C. L., Wang, X., Lundgren, A. D., & Wu, J. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903789 · Cited by 131
Gasche, Y., Soccal, P. M., Kanemitsu, M., & Copin, J.-C. (2006) · Frontiers in bioscience · doi:10.2741/1883 · Cited by 130
IL-7 inhibits fibroblast TGF-β production and signaling in pulmonary fibrosis
Huang, M., Sharma, S. P., Zhu, L. X., Keane, M. P., Luo, J., Zhang, L., Burdick, M. D., Lin, Y. Q., Dohadwala, M., Gardner, B. K., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214685 · Cited by 129
Tumor cell-selective cytotoxicity of matrix metalloproteinase-activated anthrax toxin.
Liu, S., Netzel–Arnett, S., Birkedal‐Hansen, H., & Leppla, S. H. (2000) · PubMed · Cited by 128
Matrix Metalloproteinases in Diabetic Kidney Disease
García-Fernández, N., Jacobs-Cachá, C., Mora‐Gutiérrez, J. M., Vergara, A., Orbe, J., & Soler, M. J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020472 · Cited by 127
Butler, G. S., Apte, S., Willenbrock, F. W., & Murphy, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10846 · Cited by 124
Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression
Stallings‐Mann, M. L., Waldmann, J., Zhang, Y., Miller, E. E., Gauthier, M. L., Visscher, D. W., Downey, G. P., Radisky, E. S., Fields, A. P., & Radisky, D. C. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004062 · Cited by 123
Matrix Metalloprotease Triggered Delivery of Cancer Chemotherapeutics from Hydrogel Matrixes
Tauro, J. R., & Gemeinhart, R. A. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501303 · Cited by 121
Stomrud, E., Björkqvist, M., Janciauskiene, S. M., Minthon, L., & Hansson, O. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt44 · Cited by 119
Yang, J. H., Kuang, X.-R., Lv, P.-T., & Yan, X.-X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2628-z · Cited by 118
Matrix Metalloproteinase-19 Is a Key Regulator of Lung Fibrosis in Mice and Humans
Yu, G., Kovkarova-Naumovski, E., Jara, P., Parwani, A. V., Kass, D. J., Ruiz, V., López-Otín, C., Rosas, I. O., Gibson, K. F., Cabrera, S., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201202-0302oc · Cited by 117
Therapeutic antibody engineering by high efficiency cell screening
Doerner, A., Rhiel, L., Zielonka, S., & Kolmar, H. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.11.025 · Cited by 116
New and Paradoxical Roles of Matrix Metalloproteinases in the Tumor Microenvironment
Noël, A., Gutiérrez‐Fernández, A., Sounni, N. E., Behrendt, N., Maquoi, E., Lund, I. K., Cal, S., Høyer‐Hansen, G., & López-Otı́n, C. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00140 · Cited by 116
Guédez, L., McMarlin, A., Kingma, D. W., Bennett, T. A., Stetler‐Stevenson, M., & Stetler‐Stevenson, W. G. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64070-9 · Cited by 115
Justilien, V., Regala, R. P., Tseng, I., Walsh, M. P., Batra, J., Radisky, E. S., Murray, N. R., & Fields, A. P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035040 · Cited by 114
Chien, M., Carlini, A. S., Hu, D., Barback, C. V., Rush, A. M., Hall, D. J., Orr, G., & Gianneschi, N. C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja408182p · Cited by 113
The Role of Adams in Notch Signaling
Groot, A. J., & Vooijs, M. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0899-4_2 · Cited by 112
Interplay of extracellular matrix and leukocytes in lung inflammation
Wight, T. N., Frevert, C. W., Debley, J. S., Reeves, S. R., Parks, W. C., & Ziegler, S. F. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.12.003 · Cited by 112
Rivera, S., García-González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 111
Ågren, M. S., Schnabel, R., Christensen, L. H., & Mirastschijski, U. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2014.10.001 · Cited by 110
Kolb, S., Lahrtz, F., Paul, R. H., Leppert, D., Nadal, D., Pfister, H., & Fontana, A. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00247-6 · Cited by 110
Juric, V., O’Sullivan, C., Stefanutti, E., Kovalenko, M. A., Greenstein, A. E., Barry-Hamilton, V., Mikaelian, I., Degenhardt, J. D., Peng, Y., Smith, V., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207255 · Cited by 110
Activation of Matrix Metalloproteinase-3 and Agrin Cleavage in Cerebral Ischemia/Reperfusion
Solé, S., Petegnief, V., Gorina, R., Chamorro, Á., & Planas, A. M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.338 · Cited by 107
Schultz, K. M., & Anseth, K. S. (2012) · Soft Matter · doi:10.1039/c2sm27303a · Cited by 104
Stiff substrates increase YAP-signaling-mediated matrix metalloproteinase-7 expression
Nukuda, A., Sasaki, C., Ishihara, S., Mizutani, T., Nakamura, K., Ayabe, T., Kawabata, K., & Haga, H. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.24 · Cited by 104
Silva, M. C., Cheng, C., Mair, W., Almeida, S., Fong, H., Biswas, M. H. U., Zhang, Z., Huang, Y., Temple, S., Coppola, G., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.001 · Cited by 103
Huang, W., Suzuki, K., Nagase, H., Arumugan, S., Doren, S. R. V., & Brew, K. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00304-3 · Cited by 102
Pro-inflammatory effects of matrix metalloproteinase 7 in acute inflammation
Vandenbroucke, R. E., Vanlaere, I., Hauwermeiren, F. V., Wonterghem, E. V., Wilson, C. L., & Libert, C. (2013) · Mucosal Immunology · doi:10.1038/mi.2013.76 · Cited by 101
Appleby, T. C., Greenstein, A. E., Hung, M., Liclican, A. C., Velasquez, M., Villaseñor, A. G., Wang, R., Wong, M. H. L., Liu, X., Papalia, G. A., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.760579 · Cited by 101
Provenzano, M., Andreucci, M., Garofalo, C., Faga, T., Michael, A., Ielapi, N., Grande, R., Sapienza, P., de Franciscis, S., Mastroroberto, P., et al. (2020) · Biomolecules · doi:10.3390/biom10010154 · Cited by 99
Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice
Fragkouli, A., Tsilibary, E. C., & Tzinia, A. K. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.06.021 · Cited by 94
Martens, E., Leyssen, A., Aelst, I. V., Fiten, P., Piccard, H., Hu, J., Descamps, F. J., den Steen, P. E. V., Proost, P., Damme, J. V., et al. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.10.012 · Cited by 93
Rocks, N., Paulissen, G., Calvo, F. Q., Polette, M., Gueders, M. M., Munaut, C., Foidart, J., Noël, A., Birembaut, P. L., & Cataldo, D. D. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602990 · Cited by 93
Paemen, L. R., Martens, E., Masure, S., & Opdenakker, G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.759_a.x · Cited by 92
Mizoguchi, H., Takuma, K., Fukuzaki, E., Ibi, D., Someya, E., Akazawa, K.-H., Alkam, T., Tsunekawa, H., Mouri, A., Noda, Y., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.154724 · Cited by 91
Wong, H. L. X., Jin, G., Cao, R., Zhang, S., Cao, Y., & Zhou, Z. (2016) · Nature Communications · doi:10.1038/ncomms10824 · Cited by 90
Matrix Metalloproteinases-7 and Kidney Fibrosis
Ke, B., Fan, C., Yang, L., & Fang, X. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00021 · Cited by 88
Manzine, P. R., Ettcheto, M., Cano, A. C., Busquets, O., Marcello, E. E., Pelucchi, S., Luca, M. D., Endres, K., Olloquequi, J., Camins, A., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108661 · Cited by 87
Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression
Pahwa, S., Stawikowski, M. J., & Fields, G. B. (2014) · Cancers · doi:10.3390/cancers6010416 · Cited by 86
Bouvet, C., Gilbert, L.-A., Girardot, D., deBlois, D., & Moreau, P. R. (2005) · Hypertension · doi:10.1161/01.hyp.0000154680.44184.01 · Cited by 86
Selective Modulation of Matrix Metalloproteinase 9 (MMP-9) Functions via Exosite Inhibition
Lauer‐Fields, J. L., Whitehead, J. K., Li, S., Hammer, R. P., Brew, K., & Fields, G. B. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801438200 · Cited by 85
Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies
Roy, R., Zurakowski, D., Wischhusen, J., Frauenhoffer, C., Hooshmand, S. M., Kulke, M. H., & Moses, M. A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.462 · Cited by 84
Regulation and involvement of matrix metalloproteinases in vascular diseases
Sen, U. (2015) · Frontiers in bioscience · doi:10.2741/4378 · Cited by 84
Matrix Metalloproteinases are Involved in Cardiovascular Diseases
Azevedo, A., do Prado, A. F., Antonio, R. C., Issa, J. P. M., & Gerlach, R. F. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12282 · Cited by 83
Qi, J. H., & Anand‐Apte, B. (2015) · APOPTOSIS · doi:10.1007/s10495-014-1076-y · Cited by 82
Meng, Q., Malinovskii, V. A., Huang, W., Hu, Y., Chung, L., Nagase, H., Bode, W., Maskos, K., & Brew, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10184 · Cited by 80
Storck, S. E., & Pietrzik, C. U. (2017) · Pharmaceutical Research · doi:10.1007/s11095-017-2267-3 · Cited by 79
The Expanding Role of MT1-MMP in Cancer Progression
Knapinska, A. M., & Fields, G. B. (2019) · Pharmaceuticals · doi:10.3390/ph12020077 · Cited by 79
Hamze, A. B., Wei, S., Bahudhanapati, H., Kota, S., Acharya, K. R., & Brew, K. (2007) · Protein Science · doi:10.1110/ps.072978507 · Cited by 78
Wang, Q., Lv, L., Tang, Y., Zhang, L., & Wang, L. (2018) · Oncology Letters · doi:10.3892/ol.2018.9779 · Cited by 78
MMP-8-Responsive Polyethylene Glycol Hydrogel for Intraoral Drug Delivery
Guo, J., Sun, H., Lei, W., Tang, Y., Hong, S., Yang, H., Tay, F. R., & Huang, C. (2019) · Journal of Dental Research · doi:10.1177/0022034519831931 · Cited by 78
Arkadash, V., Yosef, G., Shirian, J., Cohen, I., Horev, Y., Grossman, M., Sagi, I., Radisky, E. S., Shifman, J. M., & Papo, N. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756718 · Cited by 77
Cardiovascular organ damage in type 2 diabetes mellitus: the role of lipids and inflammation
Kozàkovà, M., Morizzo, C., Gonçalves, I., Natali, A., Nilsson, J. Å., & Palombo, C. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0865-6 · Cited by 77
Wayne, G. J., Deng, S.-J., Amour, A., Borman, S., Matico, R., Carter, H. L., & Murphy, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610721200 · Cited by 75
Exploring the Subtleties of Drug−Receptor Interactions: The Case of Matrix Metalloproteinases
Bertini, I., Calderone, V., Fragai, M., Giachetti, A., Loconte, M., Luchinat, C., Maletta, M., Nativi, C., & Yeo, K. J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065156z · Cited by 75
Lee, M., Rapti, M., & Murphy, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305678200 · Cited by 73
Caiazza, F., McGowan, P. M., Mullooly, M., Murray, A., Synnott, N. C., O’Donovan, N., Flanagan, L., Tape, C. J., Murphy, G., Crown, J. P., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.163 · Cited by 70
Peptide-Based Selective Inhibitors of Matrix Metalloproteinase-Mediated Activities
Ndinguri, M. W., Bhowmick, M., Tokmina‐Roszyk, D., Robichaud, T. K., & Fields, G. B. (2012) · Molecules · doi:10.3390/molecules171214230 · Cited by 68
Grossman, M., Tworowski, D., Dym, O., Lee, M.-H., Levy, Y., Murphy, G., & Sagi, I. (2010) · Biochemistry · doi:10.1021/bi902141x · Cited by 68
Unraveling Hidden Regulatory Sites in Structurally Homologous Metalloproteases
Udi, Y., Fragai, M., Grossman, M., Mitternacht, S., Arad‐Yellin, R., Calderone, V., Melikian, M., Toccafondi, M., Berezovsky, I. N., Luchinat, C., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.04.009 · Cited by 68
Shao, S.-H., Li, Z., Gao, W., Yu, G., Liu, D., & Pan, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085936 · Cited by 67
Duhachek-Muggy, S., Qi, Y., Wise, R., Alyahya, L., Li, H. Z., Hodge, J., & Żółkiewska, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0599-6 · Cited by 67
Batra, J., Robinson, J., Mehner, C., Hockla, A., Miller, E. E., Radisky, D. C., & Radisky, E. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050028 · Cited by 66
TIMP-1 Alters Susceptibility to Carcinogenesis
Rhee, J.-S., Diaz, R. J., Korets, L. V., Hodgson, J., & Coussens, L. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2445 · Cited by 66
Chen, W., Luo, G., Qiu, W., Lei, Q., Liu, L., Zheng, D., Hong, S., Cheng, S., & Zhang, X. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b03236 · Cited by 66
The Recognition of Collagen and Triple-helical Toolkit Peptides by MMP-13
Howes, J., Bihan, D. G., Slatter, D. A., Hamaia, S. W., Packman, L. C., Knäuper, V., Visse, R., & Farndale, R. W. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.583443 · Cited by 65
Inhibition Mechanism of Membrane Metalloprotease by an Exosite-Swiveling Conformational Antibody
Udi, Y., Grossman, M., Solomonov, I., Dym, O., Rozenberg, H., Moreno, V., Cuniasse, P., Dive, V., Arroyo, A. G., & Sagi, I. (2014) · Structure · doi:10.1016/j.str.2014.10.012 · Cited by 64
Kolb, C., Mauch, S., Peter, H., Krawinkel, U., & Sedlacek, R. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00057-6 · Cited by 63
Sandborn, W. J., Bhandari, B. R., Fogel, R., Onken, J. E., Yen, E., Zhao, X., Jiang, Z., Ge, D., Xin, Y., Ye, Z., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13653 · Cited by 63
Overexpression of MMP-13 gene in colorectal cancer with liver metastasis.
Yamada, T., Oshima, T., Yoshihara, K., Tamura, S., Kanazawa, A., Inagaki, D., Yamamoto, N., Sato, T., Fujii, S., Numata, K., et al. (2010) · PubMed · Cited by 61
Nara, H., Kaieda, A., Sato, K., Naito, T., Mototani, H., Oki, H., Yamamoto, Y., Kuno, H., Santou, T., Kanzaki, N., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01007 · Cited by 61
Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP
Ingvarsen, S., Porse, A., Erpicum, C., Maertens, L., Jürgensen, H. J., Madsen, D. H., Melander, M. C., Gårdsvoll, H., Høyer‐Hansen, G., Noël, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447169 · Cited by 60
Li, Y., Xu, X.-B., Chen, X., Wei, G., He, B., & Wang, J.-D. (2012) · Human Reproduction · doi:10.1093/humrep/des110 · Cited by 60
Wu, K.-I. S., & Schmid‐Schönbein, G. W. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.158709 · Cited by 59
Protein Engineering of the Tissue Inhibitor of Metalloproteinase 1 (TIMP-1) Inhibitory Domain
Wei, S., Chen, Y., Chung, L., Nagase, H., & Brew, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211793200 · Cited by 58
Lee, M., Rapti, M., Knäuper, V., & Murphy, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312589200 · Cited by 58
Devel, L., Garcia, S., Czarny, B., Beau, F., Lajeunesse, E. C., Vera, L., Georgiadis, D., Stura, E. A., & Dive, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139634 · Cited by 58
Metalloproteinases in metabolic syndrome
Berg, G. A., Miksztowicz, V., & Schreier, L. E. (2011) · Clinica Chimica Acta · doi:10.1016/j.cca.2011.06.013 · Cited by 57
Cancer Gene Therapy with Tissue Inhibitors of Metalloproteinases (TIMPs)
Brand, K. (2002) · Current Gene Therapy · doi:10.2174/1566523024605564 · Cited by 57
The Balance Between Metalloproteinases and TIMPs
Masciantonio, M. G., Lee, C. K. S., Arpino, V., Mehta, S., & Gill, S. E. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.01.001 · Cited by 57
ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis
Leszczyński, P., Hendrich, A. B., Szmida, E., & Sasiadek, M. M. (2013) · BMB Reports · doi:10.5483/bmbrep.2013.46.3.176 · Cited by 55
KISS1R signaling promotes invadopodia formation in human breast cancer cell via β-arrestin2/ERK
Goertzen, C., Dragan, M., Turley, E. A., Babwah, A. V., & Bhattacharya, M. M. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.12.010 · Cited by 55
Edwards, S. T., Cruz, A. C., Donnelly, S., Dazin, P. F., Schulman, E. S., Jones, K. D., Wolters, P. J., Hoopes, C. W., Dolganov, G., & Fang, K. C. (2005) · The Journal of Pathology · doi:10.1002/path.1780 · Cited by 53
Hutton, M., Willenbrock, F. W., Brocklehurst, K., et al. (1998) · Biochemistry · doi:10.1021/bi980616p · Cited by 52
Yu, S., Liu, L.-Y., Lv, B., Che, C., Fan, D., Wang, L., & Zhang, Y. (2015) · Cell Biochemistry and Function · doi:10.1002/cbf.3118 · Cited by 52
Jenkinson, C., Elliott, V., Menon, U., Apostolidou, S., Fourkala, O. E., Gentry‐Maharaj, A., Pereira, S. P., Jacobs, I. J., Cox, T. F., Greenhalf, W., et al. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.10.001 · Cited by 51
Sandborn, W. J., Bhandari, B. R., Randall, C. W., Younes, Z. H., Romańczyk, T., Xin, Y., Wendt, E., Chai, H., McKevitt, M., Zhao, S., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy049 · Cited by 51
Inhibitory Antibodies Designed for Matrix Metalloproteinase Modulation
Fischer, T., & Riedl, R. (2019) · Molecules · doi:10.3390/molecules24122265 · Cited by 51
Raeeszadeh‐Sarmazdeh, M., Greene, K., Sankaran, B., Downey, G. P., Radisky, D. C., & Radisky, E. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008321 · Cited by 50
Self-citationShirian, J., Arkadash, V., Cohen, I., Sapir, T., Radisky, E. S., Papo, N., & Shifman, J. M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13016 · Cited by 49
Schreiber, S., Siegel, C. A., Friedenberg, K., Younes, Z. H., Seidler, U. E., Bhandari, B. R., Wang, K., Wendt, E., McKevitt, M., Zhao, S., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy070 · Cited by 49
Kinoh, H., Inoue, M., Washizawa, K., Yamamoto, T., Fujikawa, S., Tokusumi, Y., Iida, A., Nagai, Y., & Hasegawa, M. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302272 · Cited by 48
Czarny, B., Stura, E. A., Devel, L., Vera, L., Lajeunesse, E. C., Beau, F., Calderone, V., Fragai, M., Luchinat, C., & Dive, V. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301574d · Cited by 48
Matrix Metalloproteinase–induced Fibrosis and Malignancy in Breast and Lung
Radisky, D. C., & Przybylo, J. A. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200711-166dr · Cited by 48
Phage Display of Tissue Inhibitor of Metalloproteinases-2 (TIMP-2)
Bahudhanapati, H., Zhang, Y., Sidhu, S. S., & Brew, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.253328 · Cited by 47
Yosef, G., Arkadash, V., & Papo, N. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004406 · Cited by 47
Sharabi, O., Shirian, J., Grossman, M., Lebendiker, M., Sagi, I., & Shifman, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093712 · Cited by 46
Blacker, M., Noe, M. C., Carty, T. J., Goodyer, C. G., & LeBlanc, A. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01228.x · Cited by 44
Lipton, A., Leitzel, K. E., Chaudri‐Ross, H. A., Evans, D. B., Ali, S. M., Demers, L. M., HAMER, P. J., Brown-Shimer, S. L., Pierce, K., Gaur, V., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4336 · Cited by 44
Pearson, J. R. A., Zurita, F., Tomás‐Gallardo, L., Díaz-Torres, A., de la Loza, M. D. C. D., Franze, K., Martin-Bermudo, M. D., & González‐Reyes, A. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005763 · Cited by 44
Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling
Wang, Y., Zhao, Z., Yan, Y., Qiang, X., Zhou, C., Li, R., Chen, H., & Zhang, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17071036 · Cited by 44
Comparative Analysis of the ADAM and ADAMTS Families
Andreini, C., Banci, L., Bertini, I., Elmi, S., & Rosato, A. (2005) · Journal of Proteome Research · doi:10.1021/pr0500096 · Cited by 43
Polonikov, A., Рымарова, Л. В., Klyosova, E. Y., Volkova, A., Azarova, I. E., Bushueva, O. Y., Быканова, М. А., Bocharova, I., Zhabin, S. N., Churnosov, M. I., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28815 · Cited by 43
Influence of Matrix Metallopeptidase 9 on Beta-Amyloid Elimination Across the Blood-Brain Barrier
Shackleton, B., Ringland, C., Abdullah, L. I., MULLAN, M. J., Crawford, F., & Bachmeier, C. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01672-z · Cited by 43
Cited by
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
Niland, S., Riscanevo, A. X., & Eble, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010146 · Cited by 503
Jiang, H., & Li, H. (2021) · BMC Cancer · doi:10.1186/s12885-021-07860-2 · Cited by 261
Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
Alkhalifa, A. E., Al-Ghraiybah, N. F., Odum, J., Shunnarah, J. G., Austin, N., & Kaddoumi, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216288 · Cited by 212
Liver cirrhosis: An overview of experimental models in rodents
Faccioli, L. A. P., Dias, M. L., Paranhos, B. A., & dos Santos Goldenberg, R. C. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120615 · Cited by 47
Metadata
- Authors
- Raeeszadeh-Sarmazdeh, M., Do, L., & Hritz, B.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-05-25
- Volume
- 9
- Issue
- 5
- Pages
- 1313
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W3026399735
- Cited by
- 324
- References
- 246
- FWCI
- 14.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.